Comparison of streptokinase, urokinase, and recombinant tissue plasminogen activator in an in vitro model of venous thrombolysis.

[1]  M. Dake,et al.  Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. , 1994, Radiology.

[2]  K. Ouriel,et al.  Plasminogen acceleration of urokinase thrombolysis. , 1994, Journal of vascular surgery.

[3]  R. Rhodes,et al.  RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL EVALUATING SURGERY VERSUS THROMBOLYSIS FOR ISCHEMIA OF THE LOWER EXTREMITY. DISCUSSION , 1994 .

[4]  Comerota Aj,et al.  Thrombolytic therapy for deep venous thrombosis: a clinical review. , 1993, Canadian journal of surgery. Journal canadien de chirurgie.

[5]  J. Polak,et al.  Short-term response to thrombolytic therapy in deep venous thrombosis: predictive value of venographic appearance. , 1992, Radiology.

[6]  R. Green,et al.  The hemodynamics of thrombus formation in arteries. , 1991, Journal of vascular surgery.

[7]  C. Francis,et al.  Fibrinolytic therapy for venous thrombosis. , 1991, Progress in cardiovascular diseases.

[8]  F. Demsar,et al.  Dependence of Blood Clot Lysis on the Mode of Transport of Urokinase into the Clot - A Magnetic Resonance Imaging Study in Vitro , 1991, Thrombosis and Haemostasis.

[9]  G. Seabrook,et al.  Percutaneous intraarterial thrombolysis in the treatment of thrombosis of lower extremity arterial reconstructions. , 1991, Journal of vascular surgery.

[10]  V. Marder.  Bleeding complications of thrombolytic treatment. , 1990, American journal of hospital pharmacy.

[11]  B. C. Donovan,et al.  Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial. , 1990, Radiology.

[12]  D. Collen.  Molecular mechanisms of fibrinolysis and their application to fibrin‐specific thrombolytic therapy , 1987, Journal of cellular biochemistry.

[13]  V. Gurewich,et al.  A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity. , 1986, Thrombosis research.

[14]  C. Francis,et al.  Concepts of clot lysis. , 1986, Annual review of medicine.

[15]  M. Geisinger,et al.  Local thrombolysis in the treatment of thrombosed arteries, bypass grafts, and arteriovenous fistulas. , 1985, Journal of vascular surgery.

[16]  F. Roth,et al.  Catheter-lysis: indications and primary results. , 1985, International angiology : a journal of the International Union of Angiology.

[17]  B E Sobel,et al.  Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. , 1984, Circulation.

[18]  F. Elgh,et al.  The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[19]  H. Hess,et al.  Local low-dose thrombolytic therapy of peripheral arterial occlusions. , 1982, The New England journal of medicine.

[20]  V. Marder.  The use of thrombolytic agents: choice of patient, drug administration, laboratory monitoring. , 1979, Annals of internal medicine.

[21]  J. Rösch,et al.  Selective clot lysis with low-dose streptokinase. , 1974, Radiology.

[22]  T. Astrup,et al.  Fibrinogenolysis and Fibrinolysis with Tissue Plasminogen Activator, Urokinase, Streptokinase-Activated Human Globulin, and Plasmin 1 , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[23]  V. Marder,et al.  The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage. , 1967, Transactions of the Association of American Physicians.

[24]  A. Fletcher,et al.  The mechanism of clot dissolution by plasmin. , 1959, The Journal of clinical investigation.

[25]  A. Clauss,et al.  Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .